Skip to main content
. 2015 Jan 27;59(2):1052–1060. doi: 10.1128/AAC.04433-14

FIG 2.

FIG 2

Correlation of neutralization potencies (EC50) and apparent affinities (Kd) of actoxumab (black circles) and bezlotoxumab (white circles) against TcdA and TcdB, respectively, purified from strains of various ribotypes. R2 = 0.96 for TcdA/actoxumab, and R2 = 0.85 for TcdB/bezlotoxumab.